Flemming Pharma

Lamivudine Tablet

0.00


Product Name : Lamivudine Tablets


Available Strength : 100 mg, 150 mg


Available Combination : Lamivudine+Zidovudine ,Lamivudine+Zidovudine + Nevirapine tablets, Lamivudine + stavudine tablet


Packing : 10X10 Tablets/Box


Pack Insert/Leaflet : Yes


Therapeutic use : Antiviral,Anti HIV,Hepatitis Treatment


Production Capacity : 10 million tablet/month


Category:

Introduction About Lamivudine Tablets

Lamivudine tablets stand as a testament to medical advancement, playing a crucial role in the treatment of HIV/AIDS and paving the way for enhanced quality of life for individuals facing this formidable challenge. In this comprehensive guide, we explore the uses, benefits, precautions, and more surrounding Lamivudine tablets, shedding light on their remarkable impact on HIV/AIDS management and beyond.

Lamivudine, classified as a nucleoside reverse transcriptase inhibitor (NRTI), is an antiretroviral medication renowned for its effectiveness in suppressing the replication of the human immunodeficiency virus (HIV). Its mechanism of action involves hindering the reverse transcriptase enzyme, thereby impeding the virus’s ability to replicate and integrate into host cells.

Precautions and Considerations

Before commencing Lamivudine tablet therapy, consider the following precautions:

  • Medical History: Share comprehensive medical history, encompassing existing conditions and medications, with your healthcare provider.
  • Pregnancy and Breastfeeding: Consult your healthcare provider about the use of Lamivudine tablets during pregnancy and breastfeeding, as specific considerations apply.

Potential Side Effects

  • Nausea
  • Headache
  • Fatigue

Reviews

There are no reviews yet.

Be the first to review “Lamivudine Tablet”

Your email address will not be published. Required fields are marked *

Demo Title

Demo Description


Introducing your First Popup.
Customize text and design to perfectly suit your needs and preferences.

This will close in 0 seconds

Scroll to Top